Sanofi-Aventis may invest in nanotechnologies


During his first press conference as CEO of Sanofi-Aventis, Chris Viehbacher gave explanations about the strategy of the pharmaceutical group.  Among other issues, he indicated he does not exclude to abandon some research directions and invest in other ones such as nanotechnologies (article in French / webcast in English).  

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: